Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-17 July 2025
Veterinary medicines European public assessment report (EPAR): Cevac Reomune, avian reovirus vaccine (inactivated), Status: Opinion
Veterinary medicines European public assessment report (EPAR): Hemosyvet, etamsylate, Status: Opinion
Summary of opinion: Syvazul BTV 3, 17/07/2025 Positive
Summary of opinion: Nobivac L4, 12/06/2025 Positive
Summary of opinion: Nobivac LoVo L4, 12/06/2025 Positive
Human medicines European public assessment report (EPAR): Rybrevant, amivantamab, Date of authorisation: 09/12/2021, Revision: 9, Status: Authorised
Dates of 2026 Scientific Advice Working Party (SAWP) meetings and submission deadlines for scientific advice, protocol assistance, qualification of novel methodologies and HTACG/EMA parallel Joint Scientific Consultation (JSC) requests
Human medicines European public assessment report (EPAR): Nordimet, methotrexate, Date of authorisation: 18/08/2016, Revision: 25, Status: Authorised
Timetable: Annual renewal application of conditional marketing authorisation